Molecular Diagnostics

Diagnostic products

Lab21 Healthcare is a global provider of diagnostic products, supporting screening and diagnostic laboratories. Through the aquisition of Newmarket, Plasmatec and Biotec Laboratories the company has a growing portfolio of finished kits and bulk reagents, including the imminent launch of a new CMV total antibody EIA.

Lab21’s professional approach and detailed product knowledge in all its business areas, has allowed the company to become a trusted supplier to customers, distributors, aid agencies and NGO's, both large and small, throughout the world. We have become a leading supplier to national blood supply services for syphilis testing, screening more than 70% of donations throughout western Europe. Our malaria screening test is now established as the assay of choice in several major markets.

With additional new product launches in early 2010, the company will further strengthen its position as a leading diagnostic provider.